Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
2011 · Journal of Biological Chemistry · 306 citations
https://doi.org/10.1074/jbc.m110.216887
C
Chang Gong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
7.9K
Citations
35
h-index
57
i10-index
Chang Gong is an academic researcher from Northwest A&F University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer-related molecular mechanisms research & MicroRNA in disease regulation. The author has an h-index of 35, co-authored 99 publications.
ORCID: 0000-0001-5215-7497Papers by this author
worksReduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
2011 · Clinical Cancer Research · 256 citations
https://doi.org/10.1158/1078-0432.ccr-11-0071
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
2022 · Science China Life Sciences · 98 citations
https://doi.org/10.1007/s11427-021-2140-8
circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer
2022 · Molecular Cancer · 87 citations
https://doi.org/10.1186/s12943-021-01476-7
Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer
2016 · EBioMedicine · 51 citations
https://doi.org/10.1016/j.ebiom.2016.08.016
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
2018 · Nature Communications · 35 citations
https://doi.org/10.1038/s41467-018-06651-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat